Proton
1 in 6 Americans live at least 4 hours from proton beam therapy facility
More than 16% of Americans live at least a 4-hour drive from the closest proton beam therapy facility, according to data published in JAMA Network Open.
Proton beam therapy shortens breast cancer treatment, creating access for more patients
Hypofractionated postmastectomy proton radiotherapy shortened the duration of breast cancer treatment, according to results published in The Lancet Oncology.
Proton Therapy and Radiation Oncology with Isabelle Choi, MD
In this episode, host Shikha Jain, MD, speaks with Isabelle Choi, MD, about the use of proton therapy in radiation oncology, improving accessibility to radiation technology and more.
Proton partial breast radiotherapy appears effective, safe for early breast cancer
Proton therapy for partial breast irradiation provided cancer control in 100% of cases of early-stage ER-positive breast cancer, according to 3-year results from a prospective, multicenter phase 2 trial.
First-in-human study of proton FLASH radiotherapy produces ‘very promising’ results
Proton FLASH radiotherapy showed clinical feasibility in a first-in-human study of patients with cancer and painful bone metastases, according to data presented at American Society for Radiation Oncology Annual Meeting.
Does proton therapy have a role in the treatment of brain tumors?
Proton therapy (PT) is a potentially important radiation modality for primary brain tumors due to its unique dose distributions. Unlike photon radiation, PT dose is characterized by a well-defined maximal range where the majority of the dose is deposited, followed by a rapid dose falloff to zero distally within a mere few millimeters.
Amid questions about cost and access, proton therapy set for ‘big moment of change’
More than 3 decades after receiving FDA approval, proton beam radiation therapy has failed to find a footing as a go-to treatment for many cancers in the United States.